Theravance

Theravance Biopharma.: Home.

Launch date

2014

Employees

Market cap

Enterprise valuation

€317m (Public information from Sep 2024)

San Francisco California (HQ)

http://theravance.com

https://twitter.com/theravancebio https://www.linkedin.com/company/theravance-biopharma-inc-

View job openings

Revenues, earnings & profits over time

USD	2020	2021	2022	2023	2024	2025	2026
Revenues	71.9m	55.3m	51.3m	57.4m	70.6m	96.0m	118m
% growth	(2 %)	(23 %)	(7 %)	12 %	23 %	36 %	22 %
EBITDA	(226m)	(133m)	(70.6m)	(40.3m)	-	-	-
% EBITDA margin	(315 %)	(240 %)	(137 %)	(70 %)	-	-	-
Profit	(278m)	(199m)	872m	(55.2m)	(36.0m)	2.9m	17.2m
% profit margin	(387 %)	(361 %)	1699 %	(96 %)	(51 %)	3 %	15 %
EV / revenue	20.4x	23.7x	9.3x	9.8x	5.7x	4.2x	3.4x
EV / EBITDA	-6.5x	-9.9x	-6.8x	-13.9x	-	-	-
R&D budget	261m	194m	63.4m	40.6m	-	-	-
R&D % of revenue	363 %	350 %	123 %	71 %	-	-	-

Date	Investors	Amount	Round
Oct 2004	N/A	N/A	IPO
May 2014	N/A	N/A	IPO
Mar 2020*	N/A	$400m	Private Placement VC
Jul 2021	N/A	$101m	IPO
Total Funding		€364m

Tech stackLearn more about the technologies and tools that this company uses.